Clinical Trials Directory

Trials / Conditions / Unresectable

Unresectable

13 registered clinical trials studyying Unresectable — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepa
NCT07535840
Tongji HospitalN/A
RecruitingEarly Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC
NCT07155850
BetaGlue Therapeutics SpAN/A
RecruitingStudy of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT06418061
Innovent Biologics (Suzhou) Co. Ltd.Phase 1
RecruitingA Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
NCT06678659
Recursion Pharmaceuticals Inc.Phase 1 / Phase 2
RecruitingPACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
NCT06102057
TheraOpPhase 2
UnknownConversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma
NCT05449483
Tianjin Medical University Cancer Institute and HospitalPhase 2
CompletedDurvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
NCT03822351
MedImmune LLCPhase 2
Active Not RecruitingA Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Tr
NCT03093922
Memorial Sloan Kettering Cancer CenterPhase 2
TerminatedGanitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas
NCT01318642
NantBioScience, Inc.Phase 2
CompletedIMCgp100 in Advanced Unresectable Melanoma
NCT01209676
University of PennsylvaniaEARLY_Phase 1
CompletedOxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metasta
NCT00952003
Arbeitsgemeinschaft medikamentoese TumortherapiePhase 2
UnknownSongyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma
NCT00805896
Fudan UniversityPhase 2
CompletedCetuximab + Gemox in Biliary Tract Cancer
NCT01216345
Association of Research on the Biology of Liver TumorsPhase 2